| Literature DB >> 33938588 |
Abhimanyu Mahajan1, Rasheda El-Nazer2, Shilpa Chitnis2.
Abstract
Entities:
Keywords: COVID-19; education; movement disorders; online
Mesh:
Year: 2021 PMID: 33938588 PMCID: PMC8242782 DOI: 10.1002/mds.28648
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 9.698
FIG. 1Pre‐COVID‐19 state of movement disorders education. [Color figure can be viewed at wileyonlinelibrary.com]
Curriculum of the movement disorders virtual educational program
| Number | Topic | Speaker |
|---|---|---|
| 1 | Functional movement disorders | Prof. Alberto Espay |
| 2 | Drug‐induced movement disorders | Prof. Richard Dewey |
| 3 | Nonmotor symptoms of Parkinson's disease | Prof. K. Ray Chaudhuri |
| 4 | Musician's dystonia | Prof. Steven Frucht |
| 5 | Pearls and pitfalls in cervical dystonia | Prof. Hubert Fernandez |
| 6 | Leadership and professional development | Prof. Shilpa Chitnis |
| 7 | Instructional cases in movement disorders | Prof. Stephen Reich |
| 8 | DBS in general sensing and closed‐loop DBS | Prof. Helen Bronte Stewart |
| 9 | Parkinson's syndromes, clinical clues | Prof. Stephen Reich |
| 10 | Pearls and pitfalls in the treatment of selected movement disorders | Prof. Alberto Espay |
| 11 | Prodromal Parkinson's disease | Prof. Tanya Simuni |
| 12 | Dystonia | Prof. Cynthia Comella |
| 13 | Clinical approach to movement disorders/phenomenology | Prof. Steven Frucht |
| 14 | Deep brain stimulation in movement disorders | Prof. Michael S. Okun |
| 15 | The clinical spectrum of tremors | Prof. Stephen Reich |
| 16 | Myoclonus: recognition and treatment | Prof. Alberto Espay |
| 17 | Freezing of gait in Parkinson's disease | Dr. Mitra Afshari |
| 18 | Disease modification trials in Parkinson's disease | Prof. Tanya Simuni |
| 19 | Tauopathies | Prof. Irene Litvan |
| 20 | Palliative care in Parkinson's disease | Dr. Jori Fleisher |
| 21 | Etiology and pathophysiology of dystonia | Prof. Mark Hallett |
| 22 | Approach to chorea | Prof. Ruth Walker |
| 23 | General diagnostic approach and Rx of ataxia | Dr. Natalie Witek |
| 24 | Update on Huntington's disease | Dr. Martha Nance |
| 25 | Getting started in clinical trials research | Profs. Raj Pahwa, Hubert Fernandez, Tanya Simuni, and Robert Hauser |
| 26 | The case for reinventing Parkinson's disease | Prof. Alberto Espay |
| 27 | Integrative medicine in Parkinson's disease | Prof. Indu Subramaniam |
| 28 | When do disorders of movement become movement disorders | Prof. Alberto Espay |
| 29 | Pediatric movement disorders | Dr. Jeff Waugh |
| 30 | Movement disorders potpourri—learning from my instructive cases | Prof. Kailash Bhatia |
| 31 | Challenges and opportunities in Rx of orthostatic hypotension | Prof. Alberto Espay |
| 32 | Targeted therapies in Parkinson's disease | Prof. Susanne Schneider |
| 33 | Clinical trials in alpha synuclein therapy | Prof. Anthony Lang |
| 34 | Tic disorders | Prof. Joseph Jankovic |
| 35 | Movement disorders emergencies | Prof. Peter Lynch |
FIG. 2Feedback on the virtual movement disorders educational program. [Color figure can be viewed at wileyonlinelibrary.com]